Literature DB >> 32947091

Bosniak classification of cystic renal masses version 2019 does not increase the interobserver agreement or the proportion of masses categorized into lower Bosniak classes for non-subspecialized readers on CT or MR.

Eduardo Oliveira Pacheco1, Ulysses S Torres2, Aldo Maurici Araújo Alves3, Daniel Bekhor3, Giuseppe D'Ippolito2.   

Abstract

PURPOSE: In a condition so prevalent as renal cysts, classifications should display satisfactory reproducibility not only among subspecialized readers. We aimed to compare the interobserver agreement of the Bosniak classification version 2019 (BC19) and current Bosniak classification (CBC) for non-subspecialized readers on CT and MRI and to verify whether BC19 leads to a downgrade of renal cystic masses when compared to CBC.
METHODS: We evaluated 50 renal cystic masses in 47 patients on MR and CT (25 per method). Eighteen readers (nine third-year radiology residents and nine abdominal imaging fellows) assessed the images using BC19 and CBC with an eight-week interval. Kappa statistic was used to assess agreement. An average score of Bosniak categories across all raters evaluated if there was downgrading of lesions on BC19.
RESULTS: The highest values of Kappa were found for fellows on CBC-MR (κ = 0.51), and the lowest values were found for residents on CBC-MR and fellows on BC19-MR (both κ = 0.36). On CBC, interobserver agreement was moderate for MR and CT (κ = 0.42 and 0.43, respectively), whereas on BC19, it was fair (κ = 0.38 and 0.40, respectively). The best agreements were in categories I (κ = 0.49-0.69) and IV (κ = 0.45-0.51). The poorest agreements occurred at IIF (κ = 0.18 on BC19-CT). There was a moderate median increase from CBC to BC19 in terms of Bosniak categories for both methods (MR [Z=-2.058, p = 0.040] and CT [Z=-2.509, p = 0.012]).
CONCLUSION: BC19, when compared to CBC, did not improve interobserver agreement nor diminished the proportion of masses categorized into lower Bosniak classes among non-subspecialized readers.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bosniak classification; CT; Inter-rater agreement; MR; Renal cyst

Year:  2020        PMID: 32947091     DOI: 10.1016/j.ejrad.2020.109270

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  5 in total

1.  Bosniak Classification version 2019: validation and comparison to original classification in pathologically confirmed cystic masses.

Authors:  Jin Hui Yan; Jason Chan; Heba Osman; Javeria Munir; Sumaya Alrasheed; Trevor A Flood; Nicola Schieda
Journal:  Eur Radiol       Date:  2021-05-21       Impact factor: 5.315

2.  CT-based Bosniak classification of cystic renal lesions: is version 2019 an improvement on version 2005?

Authors:  Jérémy Dana; Simon Gauvin; Michelle Zhang; Jose Lotero; Christopher Cassim; Giovanni Artho; Sahir Rai Bhatnagar; Simon Tanguay; Caroline Reinhold
Journal:  Eur Radiol       Date:  2022-09-01       Impact factor: 7.034

3.  Interrater Agreement of Bosniak Classification Version 2019 and Version 2005 for Cystic Renal Masses at CT and MRI.

Authors:  Kimberly L Shampain; Prasad R Shankar; Jonathan P Troost; Maarten L Galantowicz; Rudra A Pampati; Taylor R Schoenheit; David A Shlensky; Daniel Barkmeier; Nicole E Curci; Ravi K Kaza; Shokoufeh Khalatbari; Matthew S Davenport
Journal:  Radiology       Date:  2021-11-02       Impact factor: 11.105

4.  Malignancy risk stratification of cystic renal lesions based on a contrast-enhanced CT-based machine learning model and a clinical decision algorithm.

Authors:  Jérémy Dana; Thierry L Lefebvre; Peter Savadjiev; Sylvain Bodard; Simon Gauvin; Sahir Rai Bhatnagar; Reza Forghani; Olivier Hélénon; Caroline Reinhold
Journal:  Eur Radiol       Date:  2022-01-23       Impact factor: 5.315

5.  Inter-observer and intra-observer agreement of Bosniak classification of cystic renal masses: Comparison between original version to version 2019 and effect of an online support calculator.

Authors:  Heba Osman; Jin Hui Yan; Jason Chan; Javeria Munir; Sumaya Alrasheed; Satheesh Krishna; Nicola Schieda
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.